Related Experiment Video
Updated: Jun 17, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Abnormal immunity and stem/progenitor cells in acquired aplastic anemia
Jian Ping Li1, Cui Ling Zheng, Zhong Chao Han
1State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, 288 Nanjing Road, Tianjin 300020, PR China.
Critical Reviews in Oncology/Hematology
|January 5, 2010
Summary
Acquired aplastic anemia involves immune system dysfunction damaging bone marrow stem cells. New therapies targeting this immune attack are needed for better patient outcomes.
Area of Science:
- Hematology
- Immunology
- Stem Cell Biology
Background:
- Acquired aplastic anemia (AA) is an immune-mediated bone marrow failure.
- Pathogenesis involves abnormal immune responses leading to pancytopenia.
Purpose of the Study:
- To elucidate the immune mechanisms underlying acquired aplastic anemia.
- To identify potential therapeutic targets for AA.
Main Methods:
- Analysis of immune cell activation and cytokine networks in AA.
- Assessment of stem and progenitor cell function.
Main Results:
- Activated immune cells and a pro-inflammatory cytokine network contribute to stem cell destruction.
- Deficiencies in regulatory immune cells and growth factors impair hematopoiesis.
- Stem/progenitor cells exhibit impaired proliferation, differentiation, and survival.
Conclusions:
- Immune dysregulation is central to acquired aplastic anemia pathogenesis.
- Current treatments like transplantation and immunosuppression have limitations.
- Patient-specific induced pluripotent stem cells offer a promising future therapeutic avenue.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:40Cell-mediated Immune Responses
Overview
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...